Cision PR Newswire

FinVolution and NUS Business School share project findings focusing on Financial Inclusion for Filipino Overseas Domestic Helpers at UN Global Compact BRI Summit

SINGAPORE, Sept. 4, 2026 /PRNewswire/ -- FinVolution Group (NYSE: FINV), a leading fintech company, took part in the Second Global Summit on High-Quality Belt and Road...

Aurzen Introduces “Unfold the Art,” a New Creative Chapter Inspired by Basquiat for Portable Projection

IRVINE, Calif., Sept. 4, 2026 /PRNewswire/ -- Aurzen today announced "Unfold the Art," a...

LaserPecker Set to Unveil U1 at IFA 2026: Live Demos of Intelligent UV Laser Engraving

BERLIN, Sept. 4, 2026 /PRNewswire/ -- Introducing the LaserPecker U1 — a UV laser engraver...

Haier Announces Global Partnership with UEFA Champions League

New brand building milestone deepens Haier's global consumer connections BERLIN, Sept. 4, 2026...

IKEA Thailand Reframes Children’s Furniture Through the Eyes of Mothers in “For All She Carries”

BANGKOK, Sept. 4, 2026 /PRNewswire/ -- This Mother's Day, IKEA Thailand looks beyond who...

HASHKEY GLOBAL PARTNERS WITH VERIFYVASP TO EXPAND GLOBAL TRAVEL RULE COMPLIANCE

Strategic partnership strengthens regulatory compliance across HashKey Global's international exchange network. SINGAPORE, March 10, 2025 /PRNewswire/ -- HashKey Global, a leading licensed exchange,...

RiboX Therapeutics Announces First Patient Dosed in Phase I/IIa Clinical Trial of RXRG001, the First Circular RNA Therapy for the Treatment of Radiation-Induced Xerostomia...

PRINCETON, N.J., March 10, 2025 /PRNewswire/ -- RiboX Therapeutics Ltd. (RiboX), a pioneering biopharmaceutical company, focused on discovering and developing fully engineered circular RNA therapeutics,...

China Telecom and Partners Innovate Together! 5G UAV Medical Delivery Network Wins Global Mobile Award

HONG KONG, March 10, 2025 /PRNewswire/ -- On March 5, during the 2025 Mobile World Congress (MWC25), the 5G UAV medical delivery network solution jointly...

AIM Vaccine’s Iteratively Upgraded Diploid Rabies Vaccine Approved for Clinical Trials, Showing Significantly Higher Efficacy than Marketed Diploid Rabies Vaccines

HONG KONG, March 10, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 9, 2025,...